Our firm represented Cimatron (NASDAQ:CIMT), a leading global provider of integrated CAD/CAM software solutions for the tool making and manufacturing industries, in its $15.7 million secondary and $6.2 million follow-on public offerings of Ordinary Shares on NASDAQ.
Meitar defended Makhteshim, one of Israel’s largest agrochemicals producers, in three mass tort actions filed by plaintiffs alleging injuries caused by air pollution from the Makhteshim plant in the “Ramat-Hovav” Industrial Zone south of Beersheva (additional defendants in this action included the State of Israel, the local municipality and other plants in the area). On January 1, 2013 the Beersheva District Court dismissed the actions in their entirety and made significant awards to the defendants for legal costs and attorneys fees. The plaintiffs have filed an appeal with the Supreme Court, which is pending.
Our firm represented Needham & Company and Oppenheimer & Co in the $32 million ordinary shares of Ceragon Networks on NASDAQ.
Meitar successfully represented Israeli cellular operators Partner and Cellcom in opposing motions to certify class actions against them related to the battery life of cellular devices. The motions were withdrawn.
Meitar represented Sapiens (TASE and NASDAQ: SPNS), a leading global provider of software solutions for the insurance industry, in its $40 million public offering.
Meitar represented the baby food importer Heinz – Remedia and the former CEO of the company in criminal proceedings involving charges of involuntary manslaughter arising from allegations of tainted baby formula. After five years of litigation, the court acquitted the former CEO of all charges relating to the baby formula. The State has filed an appeal of the acquittal, which is still pending.
Our firm represented Barclays Capital Inc. and Citigroup Global Markets Inc. in the $1.4 billion global notes offering by Israel Electric Corporation.
